.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Teva
Argus Health
Fuji
Cipla
US Department of Justice
Mallinckrodt
Boehringer Ingelheim
Baxter
Farmers Insurance

Generated: June 24, 2017

DrugPatentWatch Database Preview

ATRACURIUM BESYLATE Drug Profile

« Back to Dashboard

Which patents cover Atracurium Besylate, and when can generic versions of Atracurium Besylate launch?

Atracurium Besylate is a drug marketed by West-ward Pharms Int, Aurobindo Pharma Ltd, Baxter Hlthcare, Hospira, Watson Pharms Teva, Baxter Hlthcare Corp, Hospira Inc, Teva Parenteral, Nanjing King-friend, Mylan Labs Ltd, and Watson Labs Inc. and is included in twenty-one NDAs.

The generic ingredient in ATRACURIUM BESYLATE is atracurium besylate. There are sixteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.

Summary for Tradename: ATRACURIUM BESYLATE

Patents:0
Applicants:11
NDAs:21
Suppliers / Packagers: see list4
Bulk Api Vendors: see list55
Clinical Trials: see list103
Patent Applications: see list400
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATRACURIUM BESYLATE at DailyMed

Pharmacology for Tradename: ATRACURIUM BESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION074901-001Jul 18, 1997APRXNoYes► Subscribe► Subscribe
Watson Labs Inc
ATRACURIUM BESYLATE PRESERVATIVE FREE
atracurium besylate
INJECTABLE;INJECTION074944-001Jul 28, 1998DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare Corp
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION074753-001Jan 23, 1997DISCNNoNo► Subscribe► Subscribe
Hospira
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION074632-001Dec 23, 1996DISCNNoNo► Subscribe► Subscribe
Mylan Labs Ltd
ATRACURIUM BESYLATE PRESERVATIVE FREE
atracurium besylate
INJECTABLE;INJECTION206001-001Apr 7, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
Express Scripts
UBS
Julphar
Boehringer Ingelheim
Argus Health
Covington
Chubb
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot